These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15148733)

  • 1. [Recent changes in glaucoma management].
    Tomita G
    Nippon Ganka Gakkai Zasshi; 2004 Apr; 108(4):191-2. PubMed ID: 15148733
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological considerations in the treatment of glaucoma.
    Fiscella RG
    Manag Care; 2002 Jan; 11(1 Suppl):16-20; discussion 24-7. PubMed ID: 11842587
    [No Abstract]   [Full Text] [Related]  

  • 3. Reappraising first-line treatment in glaucoma management.
    Phelan P
    Hosp Med; 2002 Sep; 63(9):540-5. PubMed ID: 12357857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood-aqueous barrier changes after the use of prostaglandin analogues in patients with pseudophakia and aphakia: a 6-month randomized trial.
    Arcieri ES; Santana A; Rocha FN; Guapo GL; Costa VP
    Arch Ophthalmol; 2005 Feb; 123(2):186-92. PubMed ID: 15710814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Theoretical and clinical aspects of the use of prostaglandins in glaucoma therapy].
    Wierzbowska J; Stankiewicz A
    Klin Oczna; 2004; 106(3):352-9. PubMed ID: 15515325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Travoprost compared with other prostaglandin analogues or timolol in patients with open-angle glaucoma or ocular hypertension: meta-analysis of randomized controlled trials.
    Li N; Chen XM; Zhou Y; Wei ML; Yao X
    Clin Exp Ophthalmol; 2006 Nov; 34(8):755-64. PubMed ID: 17073898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prostaglandin wars.
    Kaufman PL
    Am J Ophthalmol; 2003 Oct; 136(4):727-8. PubMed ID: 14516814
    [No Abstract]   [Full Text] [Related]  

  • 8. Additivity of bimatoprost or travoprost to latanoprost in glaucomatous monkey eyes.
    Gagliuso DJ; Wang RF; Mittag TW; Podos SM
    Arch Ophthalmol; 2004 Sep; 122(9):1342-7. PubMed ID: 15364714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of monotherapy treatment of glaucoma and ocular hypertension with the lipid class of medications.
    Kymes S
    Am J Ophthalmol; 2006 Aug; 142(2):354; author reply 354-5. PubMed ID: 16876536
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostaglandin analogs and blood-aqueous barrier integrity: a flare cell meter study.
    Cellini M; Caramazza R; Bonsanto D; Bernabini B; Campos EC
    Ophthalmologica; 2004; 218(5):312-7. PubMed ID: 15334011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of monotherapy treatment of glaucoma and ocular hypertension with the lipid class of medications.
    Noecker RJ; Walt JG
    Am J Ophthalmol; 2006 Jan; 141(1 Suppl):S15-21. PubMed ID: 16389056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin-timolol fixed combinations efficacy: myth or reality?
    Konstas AG; Haidich AB; Rossetti L; Webers C
    Eur J Ophthalmol; 2012; 22(1):1-4. PubMed ID: 22167537
    [No Abstract]   [Full Text] [Related]  

  • 13. Ocular surface tolerability of prostaglandin analogs in patients with glaucoma or ocular hypertension.
    Whitson JT; Trattler WB; Matossian C; Williams J; Hollander DA
    J Ocul Pharmacol Ther; 2010 Jun; 26(3):287-92. PubMed ID: 20578283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The more favourable cost/effectiveness ratio of latanoprost vs bimatoprost and travoprost when using normally for treatment of glaucoma].
    Soto J
    Arch Soc Esp Oftalmol; 2005 Jan; 80(1):9-10; author reply 10. PubMed ID: 15692888
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of topical prostaglandin analog use on outcome following selective laser trabeculoplasty.
    Scherer WJ
    J Ocul Pharmacol Ther; 2007 Oct; 23(5):503-12. PubMed ID: 17941809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperemia-associated costs of medication changes in glaucoma patients treated initially with prostaglandin analogs.
    Schwartz GF; Tan J; Kotak S
    J Ocul Pharmacol Ther; 2009 Dec; 25(6):555-61. PubMed ID: 20028264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of travoprost, latanoprost and bimatoprost on ocular circulation: a 6-month clinical trial.
    Koz OG; Ozsoy A; Yarangumeli A; Kose SK; Kural G
    Acta Ophthalmol Scand; 2007 Dec; 85(8):838-43. PubMed ID: 17680841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-offset analysis: bimatoprost versus other prostaglandin analogues in open-angle glaucoma.
    Berenson KL; Kymes S; Hollander DA; Fiscella R; Burk C; Patel VD
    Am J Manag Care; 2011 Sep; 17(9):e365-74. PubMed ID: 21902444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular hypotensive efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension.
    Cantor LB; WuDunn D; Cortes A; Hoop J; Knotts S
    Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S12-8. PubMed ID: 15016557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analytic review of bimatoprost, latanoprost and travoprost in primary open angle glaucoma.
    Holmstrom S; Buchholz P; Walt J; Wickstrøm J; Aagren M
    Curr Med Res Opin; 2005 Nov; 21(11):1875-83. PubMed ID: 16307709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.